Ildstad Suzanne

Related Filers (1)

Other (1)

144
Friday, 4/21/2023
Filing for proposed sale of securities under Rule 144
Show More

Ownership (15)

4
Friday, 4/21/2023
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/19/2023
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Friday, 4/7/2023
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Friday, 4/7/2023
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Friday, 4/7/2023
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Friday, 4/7/2023
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Friday, 4/7/2023
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/20/2023
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/7/2023
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/2/2023
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/23/2023
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/21/2023
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/23/2022
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/2/2022
Talaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 5/6/2021
Talaris Therapeutics, Inc.: Initial statement of beneficial ownership of securities
Show More